Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 4Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 17Carcinoma, Hepatocellular 5Recurrence 4Neoplasms, Plasma Cell 4Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Liver Neoplasms 3Sarcoma 2NSCLC 2Lymphoma, Large B-Cell, Diffuse 2Esophageal Neoplasms 2Waldenstrom Macroglobulinemia 1Stomach Neoplasms 1Pathologic Complete Response 1Osteosarcoma 1Neoplasms, Second Primary 1Neoplasms 1Melanoma 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Large Granular Lymphocytic 1Leiomyosarcoma 1Kidney Neoplasms 1Immunoglobulin Light-chain Amyloidosis 1Immunoblastic Lymphadenopathy 1Glioblastoma 1Extrapancreatic Neuroendocrine Tumor 1Colonic Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Cyclophosphamide 4Dexamethasone 3sargramostim 2Bortezomib 2pomalidomide 1isatuximab 1elotuzumab 1dexamethasone acetate 1dexamethasone 21-phosphate 1daratumumab 1auricularum 1Thalidomide 1Technetium Tc 99m Pyrophosphate 1Technetium 1Registries 1Radiotherapy 1Pharmacogenomic Testing 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Lenalidomide 1Ketamine 1Filgrastim 1Carboplatin 1Calcium Dobesilate 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Immunoglobulin Light-chain Amyloidosis × Thalidomide × Clear all
NCT04612582 2020-11-03

Comparison of BTD and BCD Based Regimens in the Treatment of AL Amyloidosis

Guangdong Provincial People's Hospital

Phase 4 Unknown
70 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡